title: Immune response and resistance to infectious bursal disease virus of chicken lines selected for high or low antibody response to Escherichia coli.
abstract: Two experimental broiler lines were developed by divergent selection for high (HH) and low (LL) antibody response to Escherichia coli. Antibody response of these lines to immunization with a commercial vaccine (whole inactivated virus, WIV) against infectious bursal disease virus (IBDV) or with proteins VP2 and VP3 of that virus, and their resistance to challenge with a virulent IBDV, were tested. The study was performed with 213 male and female chicks from the tenth generation of the HH and LL lines. At 15 d of age, after disappearance of maternal antibodies, chicks from each line were randomly divided into four groups and injected with WIV, VP2, VP3, or adjuvant alone as a negative control. Chicks were bled 18 d postinjection, and antibody titers were determined by ELISA. Ten days later, the chicks were challenged with a virulent strain of the virus and killed after 10 d; the ratio of bursa of Fabricius to 100 g BW was determined for each bird. Significant differences in antibody titers were found among immunized and control chicks. Chicks from the HH line exhibited significantly higher antibody titers than LL chicks in response to WIV and VP2 vaccines but not to VP3 vaccine. Following challenge, bursa weight (relative to BW) of HH and LL chicks vaccinated with WIV and VP2 was significantly higher (P < 0.01) than that of chicks vaccinated with VP3 or the challenged unvaccinated control. No difference was found in this parameter between the latter two groups. Possible explanations for the differences in the line response to VP2 and VP3 are discussed.
authors.affiliation: Migal, Kiryat Shmona, Rosh-Pinah, Israel.
authors.forename: J
authors.initials: J
authors.lastname: Pitcovski
authors.forename: A
authors.initials: A
authors.lastname: Cahaner
authors.forename: E D
authors.initials: ED
authors.lastname: Heller
authors.forename: T
authors.initials: T
authors.lastname: Zouri
authors.forename: B
authors.initials: B
authors.lastname: Gutter
authors.forename: Y
authors.initials: Y
authors.lastname: Gotfried
authors.forename: G
authors.initials: G
authors.lastname: Leitner
mesh_terms: D000818:Animals; D000907:Antibodies, Bacterial / Q000096:biosynthesis; D000914:Antibodies, Viral / Q000096:biosynthesis; D018175:Birnaviridae Infections / Q000276:immunology / Q000662:veterinary*; D001835:Body Weight; D002060:Bursa of Fabricius / Q000033:anatomy & histology / Q000276:immunology; D002213:Capsid / Q000276:immunology; D002645:Chickens / Q000235:genetics / Q000276:immunology*; D004926:Escherichia coli / Q000276:immunology*; D005260:Female; D007113:Immunity, Innate / Q000235:genetics / Q000276:immunology*; D007243:Infectious bursal disease virus / Q000276:immunology*; D008297:Male; D009929:Organ Size; D011201:Poultry Diseases / Q000276:immunology*; D012641:Selection, Genetic; D015678:Viral Structural Proteins / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology
chemical_list: D000907:Antibodies, Bacterial; D000914:Antibodies, Viral; C082513:VP2 protein, infectious bursal disease virus; D015678:Viral Structural Proteins; D014765:Viral Vaccines